title: Pharmacogenetic screening: HLA-B(*) 5701 vs. CYP2B6 G516T.
authors.forename: A W C
authors.initials: AW
authors.lastname: Lin
authors.forename: W-C
authors.initials: WC
authors.lastname: Yam
authors.forename: H-Y
authors.initials: HY
authors.lastname: Lam
authors.forename: S
authors.initials: S
authors.lastname: To
authors.forename: D
authors.initials: D
authors.lastname: Chan
authors.forename: K C W
authors.initials: KC
authors.lastname: Chan
authors.forename: S-S
authors.initials: SS
authors.lastname: Lee
mesh_terms: D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D044466:Asian People; D065702:Cytochrome P-450 CYP2B6; D005260:Female; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy / Q000235:genetics*; D015497:HIV-1 / Q000235:genetics*; D015235:HLA-B Antigens / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010089:Oxidoreductases, N-Demethylating / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000187:drug effects / Q000235:genetics*
chemical_list: D015235:HLA-B Antigens; D001189:Aryl Hydrocarbon Hydroxylases; C585599:CYP2B6 protein, human; D065702:Cytochrome P-450 CYP2B6; D010089:Oxidoreductases, N-Demethylating